VC Tjan-Heijnen

Abstract S4-07: BELLE-3: A phase III study of buparlisib + fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic breast cancer, who progressed on or after mTOR inhibitor-based treatment

Angelo Di Leo, Keun Seok Lee, Eva Ciruelos et al. · Cancer Research · 2017 · 55 citations

Medicine, Oncology, Pharmacology +17

Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer

VC Tjan-Heijnen, IE van Hellemond, P.G.M. Peer et al. · Cancer Research · 2017 · 30 citations

Medicine, Oncology, Pharmacology +15

Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists' group (BOOG).

Maaike de Boer, CH van Deurzen, JA van Dijck et al. · Cancer Research · 2009 · 11 citations

Medicine, Oncology, Pathology +17